Tango Therapeutics, Inc. (TNGX) is a publicly traded Healthcare sector company. As of May 21, 2026, TNGX trades at $20.87 with a market cap of $2.98B and a P/E ratio of -24.47. TNGX moved +3.69% today. Year to date, TNGX is +136.59%; over the trailing twelve months it is +918.36%. Its 52-week range spans $1.03 to $28.41. Analyst consensus is strong buy with an average price target of $30.70. Rallies surfaces TNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading TNGX stock inside the company?
Recent TNGX insider activity includes Crystal Adam sold 25.90K, Crystal Adam sold 1.10K, Crystal Adam sold 38.46K, Crystal Adam sold 27.00K, and Crystal Adam sold 12.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
TNGX Key Metrics
Key financial metrics for TNGX
Metric
Value
Price
$20.87
Market Cap
$2.98B
P/E Ratio
-24.47
EPS
$-0.87
Dividend Yield
0.00%
52-Week High
$28.41
52-Week Low
$1.03
Volume
45
Avg Volume
0
Revenue (TTM)
$62.38M
Net Income
$-101.59M
Gross Margin
0.00%
Recent TNGX Insider Trades
Crystal Adam sold 25.90K (~$548.90K) on May 1, 2026.
Crystal Adam sold 1.10K (~$24.20K) on May 1, 2026.
Crystal Adam sold 38.46K (~$961.50K) on Apr 15, 2026.
Crystal Adam sold 27.00K (~$572.48K) on Apr 1, 2026.
Crystal Adam sold 12.00K (~$241.32K) on Mar 25, 2026.
Recent TNGX insider activity includes Crystal Adam sold 25.90K, Crystal Adam sold 1.10K, Crystal Adam sold 38.46K, Crystal Adam sold 27.00K, and Crystal Adam sold 12.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TNGX?
Yes. Rallies tracks TNGX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TNGX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TNGX. It does not provide personalized investment advice.
